Drug Trial News

RSS
Intensive new combination therapy for ovarian cancer shows promising results

Intensive new combination therapy for ovarian cancer shows promising results

Triplet therapy could benefit patients with BRAF-mutant metastatic colorectal cancer

Triplet therapy could benefit patients with BRAF-mutant metastatic colorectal cancer

Novel immunotherapy combination could provide fresh hope for patients with cervical cancer

Novel immunotherapy combination could provide fresh hope for patients with cervical cancer

Study: Three-drug combination improves overall survival in patients with mCRC

Study: Three-drug combination improves overall survival in patients with mCRC

Adding targeted therapy drug to standard treatment benefits aggressive breast cancer patients

Adding targeted therapy drug to standard treatment benefits aggressive breast cancer patients

Combination of two immunotherapy drugs stops or reverses progression of advanced melanoma

Combination of two immunotherapy drugs stops or reverses progression of advanced melanoma

PARP inhibitor combined with chemotherapy increases survival for newly diagnosed ovarian cancer patients

PARP inhibitor combined with chemotherapy increases survival for newly diagnosed ovarian cancer patients

Ticagrelor monotherapy reduces bleeding while preserving ischemic benefit in high-risk PCI patients

Ticagrelor monotherapy reduces bleeding while preserving ischemic benefit in high-risk PCI patients

Combination therapy may offer new therapeutic avenue for previously-treated NSCLC and kidney cancer patients

Combination therapy may offer new therapeutic avenue for previously-treated NSCLC and kidney cancer patients

Clinical trial to evaluate efficacy and safety of new treatment for giant cell arteritis

Clinical trial to evaluate efficacy and safety of new treatment for giant cell arteritis

Investigational drug may offer new treatment option for patients with lung and kidney cancer

Investigational drug may offer new treatment option for patients with lung and kidney cancer

New clinical trial tests immunotherapy drug for prostate cancer patients on active surveillance

New clinical trial tests immunotherapy drug for prostate cancer patients on active surveillance

Novel gene therapy for glycogen storage disease shows positive results

Novel gene therapy for glycogen storage disease shows positive results

Prilenia's lead compound selected to participate in first-ever ALS platform trial

Prilenia's lead compound selected to participate in first-ever ALS platform trial

IMRT and cisplatin treatment meets acceptability criteria for PFS and swallowing-related QOL

IMRT and cisplatin treatment meets acceptability criteria for PFS and swallowing-related QOL

Two uveitis drugs perform similarly in a head-to-head clinical trial

Two uveitis drugs perform similarly in a head-to-head clinical trial

New polypill cheaper, better at reducing cardiovascular disease

New polypill cheaper, better at reducing cardiovascular disease

Ticagrelor reduces heart attacks and strokes for patients with diabetes

Ticagrelor reduces heart attacks and strokes for patients with diabetes

ARNI therapy trial misses target in heart failure, may have selective benefit only

ARNI therapy trial misses target in heart failure, may have selective benefit only

Investigational drug reduces stuttering symptoms in open-label pilot study

Investigational drug reduces stuttering symptoms in open-label pilot study